Zebeta and Nail abnormalities - a phase IV clinical study of FDA data

Summary:

Nail abnormalities is reported only by a few people who take Zebeta.

The phase IV clinical study analyzes which people take Zebeta and have Nail abnormalities. It is created by eHealthMe based on reports of 1,610 people who have side effects while taking Zebeta from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

1,610 people reported to have side effects when taking Zebeta.
Among them, 2 people (0.12%) have Nail abnormalities.


What is Zebeta?

Zebeta has active ingredients of bisoprolol fumarate. It is often used in high blood pressure. eHealthMe is studying from 1,687 Zebeta users for its effectiveness, alternative drugs and more.

What is Nail abnormalities?

Nail abnormalities (abnormal nail) is found to be associated with 876 drugs and 583 conditions by eHealthMe.

Number of Zebeta and Nail abnormalities reports submitted per year:

Could Zebeta cause Nail abnormalities?

Gender of people who have Nail abnormalities when taking Zebeta *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Nail abnormalities when taking Zebeta *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Zebeta *:

  1. Prilosec: 1 person, 50.00%
  2. Lisinopril: 1 person, 50.00%
  3. Lanoxin: 1 person, 50.00%
  4. Fosamax: 1 person, 50.00%
  5. Demadex: 1 person, 50.00%
  6. Coreg: 1 person, 50.00%

Common side effects people have besides Nail abnormalities *:

  1. Skin Odor Abnormal: 1 person, 50.00%
  2. Nail Discoloration: 1 person, 50.00%
  3. Joint Pain: 1 person, 50.00%
  4. Hair Loss: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zebeta and have Nail abnormalities?

Check whether Nail abnormalities is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Nail abnormalities and when was it recovered:

Expand to all the drugs that have ingredients of bisoprolol fumarate:

Alternative drugs to, pros and cons of Zebeta:

Common Zebeta side effects:

Browse all side effects of Zebeta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Nail abnormalities treatments and more:

COVID vaccines that are related to Nail abnormalities:

Common drugs associated with Nail abnormalities:

All the drugs that are associated with Nail abnormalities:

Common conditions associated with Nail abnormalities:

All the conditions that are associated with Nail abnormalities:

How the study uses the data?

The study uses data from the FDA. It is based on bisoprolol fumarate (the active ingredients of Zebeta) and Zebeta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: